President Trump used his first State of the Union address to tout a lot of first-year accomplishments — including the tremendous progress his administration has already made in lowering drug prices for Americans. Unfortunately, these efforts remain scarcely reported.
CNBC reporter Angelica LaVito notes that even though the President “sporadically saber rattles about drug companies hiking prices,” he has not “pushed Congress to pass legislation that either would impose price controls or allow Medicare to negotiate better prices with pharmaceutical makers.” Other critics have echoed the sentiment. While the talking heads who favor of heavy-handed government intervention decry the president's supposed inaction, millions of Americans are benefitting from the administration's avoidance of price-setting.
